Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04522271 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Resistant Starch in Pediatric Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis)

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date changed from estimate of Sep 2025 to May 25, 2024
    • Study completion date: Dec 2025 to Dec 31, 2026
    v10
  2. Primary completion date: May 15, 2024 to Sep 2025
    • Study completion date: Dec 31, 2024 to Dec 2025
    v9
  3. Primary completion date changed from estimate of May 1, 2024 to May 15, 2024
    • Study completion date: May 1, 2024 to Dec 31, 2024
    v8
  4. Primary completion date: Aug 2023 to May 1, 2024
    • Study completion date: Feb 2024 to May 1, 2024
    v7
  5. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. 2 versions Re-verified since Jun 5, 2021, no change to tracked fieldsv4-v5
  2. Secondary endpoints: details revised at 7 of 8 entriesv3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Aug 2020 to Aug 25, 2020
    • Site details revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is determine if a plant-based resistant starch that is optimized for the individual will target the underlying cause of inflammatory bowel disease and restore a "healthier" gut microbiome in pediatric participants with inflammatory bowel disease.
Trial Details
NCT Number NCT04522271
Lead Sponsor Children's Hospital of Eastern Ontario
Conditions
(from sponsor)		 Crohn Disease, Ulcerative Colitis, Inflammatory Bowel Diseases
Related terms Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov